Monte Rosa Therapeutics logo

Monte Rosa Therapeutics Share Price Today

(NASDAQ: GLUE)

Monte Rosa Therapeutics share price is $4.55 & ₹388.87 as on 18 Apr 2025, 2.30 'hrs' IST

$4.55

0.14

(3.17%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Monte Rosa Therapeutics share price in Dollar and Rupees. Guide to invest in Monte Rosa Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Monte Rosa Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Monte Rosa Therapeutics share price movements

  • Today's Low: $4.20
    Today's High: $4.62

    Day's Volatility :8.99%

  • 52 Weeks Low: $3.21
    52 Weeks High: $12.40

    52 Weeks Volatility :74.11%

Monte Rosa Therapeutics (GLUE) Returns

PeriodMonte Rosa Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-20.04%
-2.8%
0.0%
6 Months
-16.51%
-11.0%
0.0%
1 Year
-22.22%
-1.9%
0.0%
3 Years
-64.31%
-1.5%
-12.9%

Monte Rosa Therapeutics (GLUE) Key Statistics

in dollars & INR

Previous Close
$4.41
Open
$4.37
Today's High
$4.615
Today's Low
$4.2
Market Capitalization
$279.9M
Today's Volume
$712.4K
52 Week High
$12.4
52 Week Low
$3.21
Revenue TTM
$75.6M
EBITDA
$-73.0M
Earnings Per Share (EPS)
$-0.98
Profit Margin
-96.14%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-36.15%

How to invest in Monte Rosa Therapeutics Stock (GLUE) from India?

It is very easy for Indian residents to invest directly in Monte Rosa Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Monte Rosa Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Monte Rosa Therapeutics or GLUE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Monte Rosa Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Monte Rosa Therapeutics shares which would translate to 0.188 fractional shares of Monte Rosa Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Monte Rosa Therapeutics, in just a few clicks!

Returns in Monte Rosa Therapeutics (GLUE) for Indian investors in Rupees

The Monte Rosa Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Monte Rosa Therapeutics investment value today

Current value as on today

₹80,119

Returns

₹19,881

(-19.88%)

Returns from Monte Rosa Therapeutics Stock

₹22,222 (-22.22%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Monte Rosa Therapeutics (GLUE)

33%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Monte Rosa Therapeutics Stock from India on INDmoney has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Monte Rosa Therapeutics

  • NEA Management Company, LLC

    12.51%

  • T. Rowe Price Associates, Inc.

    11.57%

  • Versant Venture Management LLC

    9.19%

  • FMR Inc

    9.02%

  • Baker Bros Advisors LP

    7.99%

  • venBio Select Advisor LLC

    7.06%

Analyst Recommendation on Monte Rosa Therapeutics

Rating
Trend

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Monte Rosa Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Monte Rosa Therapeutics Stock (GLUE)

What analysts predicted

Upside of 254.4%

Target:

$16.13

Current:

$4.55

Insights on Monte Rosa Therapeutics Stock (Ticker Symbol: GLUE)

  • Price Movement

    In the last 1 month, GLUE stock has moved down by -34.2%
  • GLUE vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 100.7%
  • GLUE vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 95.0%
  • Price to Sales

    ForGLUE every $1 of sales, investors are willing to pay $4.4, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

Monte Rosa Therapeutics Technicals Summary

Sell

Neutral

Buy

Monte Rosa Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Monte Rosa Therapeutics (GLUE) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Monte Rosa Therapeutics Inc logo
-37.54%
-16.51%
-22.22%
-64.31%
-76.46%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Monte Rosa Therapeutics

Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. The company develops orally bioavailable molecular glue degraders (MGDs), such as MRT-2359 for the treatment of MYC-driven tumors; MRT-6160 for the treatment of neurologic and systemic autoimmune and inflammatory diseases; and MRT-8102 for the treatment of inflammatory diseases driven by IL-1b and the NLRP3 inflammasome. In addition, it develops CDK2 to treat multiple cancers, including ovarian, endometrial, gastric and breast. Further, its pipeline includes programs in immunology and inflammation indications, oncology, cardiovascular, metabolic, and genetic diseases. The company also develops QuEEN, a discovery engine, to enable its target-centric MGD discovery and development approach and its rational design of MGD product candidates. It has a strategic collaboration and licensing agreement with F. Hoffmann-La Roche Ltd. to discover and develop MGDs against targets in cancer and neurological diseases. The company was incorporated in 2019 and is headquartered in Boston, Massachusetts.
Organization
Monte Rosa Therapeutics
Employees
134
CEO
Dr. Markus Warmuth M.D.
Industry
Services

Management People of Monte Rosa Therapeutics

NameTitle
Dr. Markus Warmuth M.D.
President, CEO & Director
Mr. Philip Nickson J.D., Ph.D.
Chief Business & Legal Officer
Dr. Filip Janku M.D., Ph.D.
Chief Medical Officer
Ms. Jennifer Champoux
Chief Operating Officer
Dr. John C. Castle Ph.D.
Chief Data & Information Officer
Dr. Sharon Townson Ph.D.
Chief Scientific Officer
Mr. Andrew Funderburk
Senior VP and Head of IR & Strategic Finance
Mr. Magnus Walter DPHIL
Senior Vice President of Drug Discovery
Mr. Edmund Dunn
Senior VP & Corporate Controller

Important FAQs about investing in GLUE Stock from India :

What is Monte Rosa Therapeutics share price today?

Monte Rosa Therapeutics share price today stands at $4.55, Open: $4.37 ; Previous Close: $4.41 ; High: $4.62 ; Low: $4.20 ; 52 Week High: $12.40 ; 52 Week Low: $3.21.

The stock opens at $4.37, after a previous close of $4.41. The stock reached a daily high of $4.62 and a low of $4.20, with a 52-week high of $12.40 and a 52-week low of $3.21.

Can Indians buy Monte Rosa Therapeutics shares?

Yes, Indians can invest in the Monte Rosa Therapeutics (GLUE) from India.

With INDmoney, you can buy Monte Rosa Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Monte Rosa Therapeutics at zero transaction cost.

How can I buy Monte Rosa Therapeutics shares from India?

It is very easy to buy Monte Rosa Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Monte Rosa Therapeutics (GLUE) be purchased?

Yes, you can buy fractional shares of Monte Rosa Therapeutics with INDmoney app.

What are the documents required to start investing in Monte Rosa Therapeutics stocks?

To start investing in Monte Rosa Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Monte Rosa Therapeutics Stock (GLUE)?

Today’s highest price of Monte Rosa Therapeutics (GLUE) is $4.62.

Today’s lowest price of Monte Rosa Therapeutics (GLUE) is $4.20.

What is today's market capitalisation of Monte Rosa Therapeutics?

Today's market capitalisation of Monte Rosa Therapeutics GLUE is 279.9M

What is the 52 Week High and Low Range of Monte Rosa Therapeutics Stock (GLUE)?

  • 52 Week High

    $12.40

  • 52 Week Low

    $3.21

What are the historical returns of Monte Rosa Therapeutics (GLUE)?

  • 1 Month Returns

    -37.54%

  • 3 Months Returns

    -16.51%

  • 1 Year Returns

    -22.22%

  • 5 Years Returns

    -76.46%

Who is the Chief Executive Officer (CEO) of Monte Rosa Therapeutics ?

Dr. Markus Warmuth M.D. is the current Chief Executive Officer (CEO) of Monte Rosa Therapeutics.